CY1794A - New use of 1,4-dihydropyridine derivatives - Google Patents
New use of 1,4-dihydropyridine derivativesInfo
- Publication number
- CY1794A CY1794A CY179495A CY179495A CY1794A CY 1794 A CY1794 A CY 1794A CY 179495 A CY179495 A CY 179495A CY 179495 A CY179495 A CY 179495A CY 1794 A CY1794 A CY 1794A
- Authority
- CY
- Cyprus
- Prior art keywords
- new use
- dihydropyridine derivatives
- formula
- calcium
- calcium antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848428552A GB8428552D0 (en) | 1984-11-12 | 1984-11-12 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1794A true CY1794A (en) | 1995-02-17 |
Family
ID=10569606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY179495A CY1794A (en) | 1984-11-12 | 1995-02-17 | New use of 1,4-dihydropyridine derivatives |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0202282B1 (xx) |
JP (1) | JPH0627069B2 (xx) |
AT (1) | ATE77952T1 (xx) |
AU (1) | AU586455B2 (xx) |
CY (1) | CY1794A (xx) |
DE (1) | DE3586321T2 (xx) |
DK (1) | DK332786D0 (xx) |
GB (1) | GB8428552D0 (xx) |
HK (1) | HK5495A (xx) |
MY (1) | MY102063A (xx) |
PH (1) | PH22606A (xx) |
SG (1) | SG79394G (xx) |
WO (1) | WO1986002836A1 (xx) |
ZA (1) | ZA858672B (xx) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103613584B (zh) * | 2013-11-27 | 2016-04-27 | 沈阳药科大学 | 一种伊拉地平合成产物后处理的方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2210667A1 (de) * | 1972-03-06 | 1973-09-20 | Bayer Ag | Kondensiert aromatisch substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE2335466A1 (de) * | 1973-07-12 | 1975-01-30 | Bayer Ag | Alkoxyalkyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DK149855C (da) * | 1977-06-20 | 1987-04-21 | Sandoz Ag | Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater |
BE886259A (fr) * | 1979-11-23 | 1981-05-20 | Sandoz Sa | Nouveaux medicament a base de derives de la 1,4-dihydropyridine, pour le traitement de l'insuffisance cerebrovasculaire ou a action spamolytique |
DE3015219A1 (de) * | 1980-04-19 | 1981-10-22 | Bayer Ag, 5090 Leverkusen | 6-amino-4,5-dihydropyridin-3-carbonsaeureester, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
US4442112A (en) * | 1981-09-02 | 1984-04-10 | Sandoz Ltd. | Dihydropyridine derivatives useful in treating vascular headaches |
FR2528431B1 (fr) * | 1982-06-15 | 1986-01-10 | Sandoz Sa | Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments |
DE3222367A1 (de) * | 1982-06-15 | 1983-12-15 | Bayer Ag, 5090 Leverkusen | Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung |
JPS597163A (ja) * | 1982-07-02 | 1984-01-14 | Yamanouchi Pharmaceut Co Ltd | 抗動脈硬化剤 |
US4656181A (en) * | 1982-11-24 | 1987-04-07 | Cermol S.A. | Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same |
DE3307422A1 (de) * | 1983-03-03 | 1984-09-06 | Bayer Ag, 5090 Leverkusen | Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen |
EP0125803A3 (en) * | 1983-04-27 | 1987-01-21 | FISONS plc | Pharmaceutically active dihydropyridines |
-
1984
- 1984-11-12 GB GB848428552A patent/GB8428552D0/en active Pending
-
1985
- 1985-11-08 EP EP85905809A patent/EP0202282B1/en not_active Expired - Lifetime
- 1985-11-08 WO PCT/EP1985/000597 patent/WO1986002836A1/en active IP Right Grant
- 1985-11-08 AT AT85905809T patent/ATE77952T1/de not_active IP Right Cessation
- 1985-11-08 AU AU51992/86A patent/AU586455B2/en not_active Ceased
- 1985-11-08 DE DE8585905809T patent/DE3586321T2/de not_active Expired - Lifetime
- 1985-11-08 JP JP60505217A patent/JPH0627069B2/ja not_active Expired - Lifetime
- 1985-11-11 PH PH33046A patent/PH22606A/en unknown
- 1985-11-12 ZA ZA858672A patent/ZA858672B/xx unknown
-
1986
- 1986-07-11 DK DK332786A patent/DK332786D0/da not_active Application Discontinuation
-
1987
- 1987-09-28 MY MYPI87002014A patent/MY102063A/en unknown
-
1994
- 1994-06-16 SG SG79394A patent/SG79394G/en unknown
-
1995
- 1995-01-12 HK HK5495A patent/HK5495A/xx not_active IP Right Cessation
- 1995-02-17 CY CY179495A patent/CY1794A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
MY102063A (en) | 1992-03-31 |
DE3586321D1 (de) | 1992-08-13 |
ATE77952T1 (de) | 1992-07-15 |
AU586455B2 (en) | 1989-07-13 |
HK5495A (en) | 1995-01-20 |
PH22606A (en) | 1988-10-17 |
EP0202282B1 (en) | 1992-07-08 |
DK332786A (da) | 1986-07-11 |
EP0202282A1 (en) | 1986-11-26 |
AU5199286A (en) | 1986-06-03 |
WO1986002836A1 (en) | 1986-05-22 |
GB8428552D0 (en) | 1984-12-19 |
ZA858672B (en) | 1987-06-24 |
JPH0627069B2 (ja) | 1994-04-13 |
JPS62500785A (ja) | 1987-04-02 |
DK332786D0 (da) | 1986-07-11 |
DE3586321T2 (de) | 1992-12-10 |
SG79394G (en) | 1994-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE10199020I2 (de) | Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit. | |
BG102425A (en) | (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors | |
ES2052871T3 (es) | Preparacion de bis (3,5-di-t-butil-4-hidroxifeniltio)metano. | |
GB9406857D0 (en) | Improvements in or relating to organic compounds | |
GB2194237B (en) | 1,2,2,6, 6-pentamethyl-4-piperidylaminotriazine derivatives and their use as stabilizers | |
NO871053L (no) | Anvendelse av substituerte n-triklormetyltiodikarboksimider i kombinasjon med n,n[-substituerte bis-(2,4-diamino-s-triazin-6-yl)-oligosulfider i vulkaniserbare kautsjukblandinger og slike kautsjukblandinger. | |
GB2177398B (en) | 5,6-epoxy-7-oxabicycloheptane substituted ethers useful in the treatment of thrombotic disease | |
ZA849576B (en) | 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases | |
SG79394G (en) | New use of 1.4-dihydropyridine derivatives. | |
IT8420213A0 (it) | Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni, in particolare per l'uso nel trattamento di psoriasi. | |
NZ219284A (en) | Fluoboric acid salt of n-tridecyl-2,6-dimethylmorpholine and pesticidal compositions | |
IT1237088B (it) | N,n'-di-(trimetossibenzoil) piperazine 2-carbonil sostituite, procedimento per preparare le stesse e composti terapeutici che le contengono. | |
DE58909244D1 (de) | Verwendung von 1,4-Dihydropyridin-Derivaten in der Behandlung von Alkoholsucht. | |
ZA913920B (en) | Therapeutic compound | |
MX12192A (es) | Composicion farmaceutica para reducir o impedir las arritmias | |
ZA845618B (en) | New 1,2-diaryl-3-azolylpropane derivatives,their preparation and their use as agents for the treatment of plants | |
IL72467A0 (en) | New 1,2-diaryl-3-azolylpropane derivatives,their preparation and their use as agents for the treatment of plants | |
IT1237087B (it) | N,n'-di-(trimetossibenzoil) piperazine 2-metossicarbonil sostituite, procedimento per preparare le stesse e composti terapeutici che le contengono. | |
IT1244562B (it) | Agente per la prevenzione ed il trattamento dell'opacita' del cristallino. | |
FI871737A0 (fi) | Kraftanlaeggning med foerbraenning i en fluidiserad baedd. | |
DE3686652D1 (de) | 1,3-dithio-2-ylidenemalonate zur heilung von fett-nekrose. | |
ATE88090T1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
MX9203508A (es) | 1,7-difenil-3-metilaza -7-ciano-8-metilnonano para usarse en el tratamiento de enfermedades. | |
ES556915A0 (es) | Mejoras en el objeto de la pat. principal n. 553.966 por perfeccionamientos introducidos en la construccion de ventiladores helicoidales. | |
ATE102035T1 (de) | Verwendung von 5-heteroaryl- oder 5arylsubstituierten imidazo(2,1-a)isochinolinen. |